[CAS NO. 1571076-26-0]  Tenofoviramibufenamide

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1571076-26-0]

Catalog
HY-137453
Brand
MCE
CAS
1571076-26-0

DESCRIPTION [1571076-26-0]

Overview

MDL-
Molecular Weight490.49
Molecular FormulaC22H31N6O5P
SMILESC[C@@H](OC[P@](OC1=CC=CC=C1)(NC(C)(C)C(OC(C)C)=O)=O)CN2C3=NC=NC(N)=C3N=C2

For research use only. We do not sell to patients.

Summary

Tenofovir amibufenamide (HS-10234), a Tenofovir prodrug, is an orally active antiviral agent. Tenofovir amibufenamide inhibits HBV , and can be used for chronic hepatitis B (CHB) study [1] [2] .


Clinical Trial

NCT Number Sponsor Condition Start Date Phase
NCT05398393 Wuhan Union Hospital, China
Hepatitis B, Chronic|Lipid Disorder
January 1, 2022 Not Applicable
NCT04477096 Jiangsu Hansoh Pharmaceutical Co., Ltd.
Healthy Subjects
August 3, 2020 Phase 1
NCT05382351 Sun Yat-sen University
Chronic Hepatitis B Virus Infection
May 10, 2022 Phase 2

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

4°C, stored under nitrogen

* In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)


Solvent & Solubility

In Vitro:

DMSO : 200 mg/mL ( 407.76 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.0388 mL 10.1939 mL 20.3878 mL
5 mM 0.4078 mL 2.0388 mL 4.0776 mL
10 mM 0.2039 mL 1.0194 mL 2.0388 mL
* Please refer to the solubility information to select the appropriate solvent.